Furthermore, systemic administration of LPS has been contributed to result in increased APP processing by β-secretase and intracellular accumulation of Aβ as well as cognitive impairment since LPS induces amyloidogenesis with concomitant increased neuroinflammation and oxidative damages [45, 46]. Here, APP is linked to Cognitive impairment.